Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure
Clinical trial NCT01219192 · UNKNOWN
Trial details
- NCT number
- NCT01219192
- Sponsor
- Protgen Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.